Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020-April 2021.

Nickel, Katelin B; Fraser, Victoria J; Babcock, Hilary M; Kwon, Jennie H

Nickel, Katelin B; Fraser, Victoria J; Babcock, Hilary M; Kwon, Jennie H.

Nickel KB; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Fraser VJ; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Babcock HM; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Kwon JH; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.

Antimicrob Steward Healthc Epidemiol ; 2(1): e169, 2022.

Article in English | MEDLINE | ID: covidwho-2120757

ABSTRACT

ABSTRACT

Coronavirus disease 2019 (COVID-19) vaccine effectiveness in the early months of vaccine availability was high among healthcare personnel (HCP) at 88.3% for 2-doses. Among those testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2), those with breakthrough infection after vaccination were more likely to have had a non-work-related SARS-CoV-2 exposure compared to unvaccinated HCP.

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Antimicrob Steward Healthc Epidemiol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google